Suicide risk is one of the most time-sensitive and least visible dangers in medicine, and the tools clinicians use to detect it are only as good as their ability to cross language and cultural barriers. A new study from Malaysia, published in BMC Psychiatry, reports that a brief, four-item questionnaire known as the Ask Suicide-Screening Questions, or ASQ, has now been successfully translated into Malay and validated against a gold-standard clinical interview in a sample of Malaysian psychiatric patients. The findings suggest that a screening instrument originally developed in English at the US National Institutes of Health can be adapted for a Southeast Asian, low- and middle-income setting without losing its diagnostic power. In a cohort of 133 psychiatric inpatients and outpatients, the Malay version of the ASQ achieved a sensitivity of 98.3 percent, meaning it flagged nearly every patient who was genuinely at risk, while its negative predictive value of 98.0 percent indicated that a negative screen almost always meant the patient was safe. For a tool that takes less than a minute to administer, those are striking numbers, and they carry significant implications for suicide prevention in regions where formal screening has historically been scarce.
The ASQ itself is deceptively simple. It consists of four yes-or-no questions that ask whether the person wishes they were dead, feels that they or their family would be better off if they were dead, has thoughts of killing themselves, and, if the answer to any of the previous questions is yes, whether they have a plan. A fifth, non-scoring question asks whether the person would like help. Because it requires no special equipment, no lengthy training, and no psychiatric expertise to administer, the ASQ was designed to be used in emergency departments, primary care clinics, and any other medical setting where patients at risk might otherwise slip through unnoticed. The instrument has been validated in multiple languages and populations around the world, but until this study it had never been formally tested in the Malay language, which is spoken by the majority of Malaysia’s population of more than thirty million people. That gap mattered, because Malaysia sits in a region where suicide rates are underreported and mental health resources are stretched thin.
Translating a suicide screening tool is not as straightforward as swapping words between languages. Questions about death and self-harm are culturally loaded, and phrasing that sounds natural in English can become stilted, ambiguous, or even offensive when rendered literally in another tongue. The research team, led by Yu Xiang Chew and Lai Fong Chan of Universiti Kebangsaan Malaysia, with contributions from Lisa M. Horowitz of the University of Colorado School of Medicine and Children’s Hospital Colorado, one of the original developers of the ASQ, used a rigorous forward-backward translation process. In this approach, one translator converts the instrument from English into Malay, and a second, independent translator converts it back into English without seeing the original. Discrepancies between the back-translated version and the source text reveal ambiguities or distortions in the Malay wording, which the team then refined iteratively. They also assessed face validity, checking whether the questions appeared to measure what they were intended to measure, and content validity, ensuring that all essential dimensions of suicide risk were preserved in the new version.
Once the Malay ASQ was finalized, the researchers put it to the test in a real clinical environment. Their sample comprised 133 psychiatric patients, both inpatients and outpatients, aged between 19 and 70 years, with a mean age of 36.1 years. Nearly three-quarters of the participants, 73.7 percent, were female, and 77.4 percent were ethnically Malay, making the cohort representative of the population for whom the translated tool is intended. The study used a blinded, sequential design that strengthens confidence in the results. First, trained medical students administered the Malay ASQ to each participant. Then, separately, psychiatry medical officers conducted a clinical interview guided by the Brief Suicide Safety Assessment, or BSSA, a structured evaluation widely regarded as a robust reference standard for determining suicide risk. Crucially, the officers conducting the BSSA were blinded to the ASQ results, so their clinical judgments could not be influenced by the screening scores, and vice versa.
The statistical results paint a picture of a screening tool that performs remarkably well where it matters most. Sensitivity, the proportion of truly at-risk patients correctly identified by the screen, came in at 98.3 percent, meaning only a small handful of genuinely endangered individuals would have been missed. Specificity, the proportion of safe patients correctly cleared, was 65.3 percent, which is moderate and means the tool produces a fair number of false positives. The positive predictive value, the likelihood that a positive screen reflects true risk, was 68.7 percent, while the negative predictive value reached 98.0 percent. Overall accuracy was 79.7 percent, and agreement between the ASQ and the clinical interview was moderate, with a Cohen’s kappa of 0.606. In screening contexts, this trade-off is exactly what clinicians want: a tool that errs on the side of caution, catching nearly everyone at risk even at the cost of flagging some patients who ultimately prove safe on fuller evaluation.
Receiver Operating Characteristic analysis, the standard method for quantifying a diagnostic test’s discriminative ability, added further weight to the findings. The area under the curve, or AUC, was 0.818 with a 95 percent confidence interval of 0.745 to 0.891, statistically significant at p less than 0.001. An AUC of 0.8 is conventionally interpreted as good discriminative validity, indicating that the Malay ASQ distinguishes between at-risk and not-at-risk patients far better than chance. For context, a perfect test would score 1.0 and a useless one 0.5, so a value above 0.8 for a four-question instrument administered in under a minute is a strong result. The study also found an interesting demographic signal: patients who screened positive on the ASQ were significantly younger than those who screened negative, with a mean age of 33.14 years compared with 41.06 years, a difference that was statistically significant at p less than 0.001. This aligns with broader epidemiological evidence that younger psychiatric patients often carry elevated suicide risk.
Why does this validation matter beyond Malaysia? The global burden of suicide falls disproportionately on low- and middle-income countries, where the majority of the world’s suicides occur, yet where systematic screening programs are rare and validated instruments in local languages are scarcer still. Many health systems in these settings rely on clinical intuition alone, which research has repeatedly shown to be unreliable, since patients rarely volunteer suicidal thoughts without being asked directly. A validated, free, rapid screening tool in the local language removes one of the biggest practical barriers to universal suicide risk screening. The Malay ASQ gives Malaysian clinicians, and potentially clinicians across the Malay-speaking world, a culturally relevant instrument that can be embedded into routine intake procedures in emergency departments, general medical wards, and psychiatric clinics alike, enabling early identification and timely management of at-risk patients before a crisis occurs.
The study’s design also offers a template for how validation research should be conducted in multilingual settings. By combining a careful forward-backward translation with face and content validity assessment, and then testing the instrument against a blinded gold-standard interview in a real patient population, the team followed best practices in cross-cultural psychometrics. The choice of the Brief Suicide Safety Assessment as the reference standard is particularly notable, because it reflects actual clinical decision-making rather than a purely academic classification. The research was funded by the Fundamental Grant for Faculty of Medicine at Universiti Kebangsaan Malaysia, and the article is open access, meaning clinicians and researchers anywhere can consult the full methodology and adapt the approach for their own languages and populations.
There are, of course, limits to what any single validation study can establish. The sample of 133 patients, while adequate for the statistical analyses performed, came from a single Malaysian psychiatric service, and the predominantly female and Malay composition may not generalize perfectly to other demographic groups or to non-psychiatric medical settings such as emergency departments, where the ASQ is often deployed. The moderate specificity of 65.3 percent also means that health systems adopting the tool must be prepared to conduct follow-up assessments on a substantial share of positive screens, which requires trained personnel and time. Still, the authors conclude that the Malay ASQ is a valid and reliable screening instrument for detecting suicide risk among psychiatric patients, and their evidence supports its use as a practical, culturally relevant tool for early identification in Malaysian settings.
The broader takeaway is a hopeful one for global mental health. Suicide is largely preventable when risk is recognized in time, and the bottleneck has rarely been treatment; it has been detection. Instruments like the ASQ, now shown to survive translation into Malay with their accuracy intact, demonstrate that effective screening does not need to be expensive, lengthy, or technologically sophisticated. Four short questions, asked with care in a patient’s own language, can surface hidden danger and open the door to help. As more health systems in resource-constrained settings adopt validated local-language screening, the invisible fraction of at-risk patients who currently go unnoticed may finally begin to shrink.
Subject of Research: Validation of the Malay-language Ask Suicide-Screening Questions for detecting suicide risk in Malaysian psychiatric patients
Article Title: Concurrent validity and screening accuracy of the Malay Ask Suicide-Screening Questions (ASQ) among a Malaysian psychiatric sample
Article References: Chew, Y. X., Vejayan, A., Lam, C. B. Y., Mokhsain, S. M. S., Ibrahim, Z., Mohd Daud, T. I., Siau, C. S., Tan, Y. K., Mohd Fauzi, M. F. F., Rahman, N. A. A., Uyub, S., Yusoff Azli Shah, S. M., Manocha, S. K., Horowitz, L. M., & Chan, L. F. (2026). Concurrent validity and screening accuracy of the Malay Ask Suicide-Screening Questions (ASQ) among a Malaysian psychiatric sample. BMC Psychiatry. https://doi.org/10.1186/s12888-026-08709-3
Image Credits: AI Generated
DOI: 10.1186/s12888-026-08709-3
Keywords: suicide screening, Ask Suicide-Screening Questions, Malay language, psychiatric patients, Malaysia, concurrent validity, sensitivity, screening accuracy, Brief Suicide Safety Assessment, cross-cultural translation, mental health, BMC Psychiatry
Cite Scienmag News
Glenn Wilkins. (October 3, 2026). Four Questions in Malay Could Catch Suicide Risk That Doctors Miss. Scienmag. https://scienmag.com/four-questions-in-malay-could-catch-suicide-risk-that-doctors-miss/
Glenn Wilkins. "Four Questions in Malay Could Catch Suicide Risk That Doctors Miss." Scienmag, 3 October 2026, https://scienmag.com/four-questions-in-malay-could-catch-suicide-risk-that-doctors-miss/. Accessed 3 October 2026.
Glenn Wilkins. "Four Questions in Malay Could Catch Suicide Risk That Doctors Miss." Scienmag. October 3, 2026. https://scienmag.com/four-questions-in-malay-could-catch-suicide-risk-that-doctors-miss/

